Taken together these data show that modifications of PDH activity consistent with HNO chemistry are generated in hepatocytes during sepsis as a result of endogenous, NOS2 -dependent NO and that intracellular levels of GSH are critical in influencing the development of HNO-derived reduction-resistant modifications. The gene discussed is PDP1; the disease is Sepsis.